NEXENTIS TECHNOLOGIES INC. Research and Development Expense
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Research and Development Expense of $373.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. research and development expense for the quarter ending 2026-06-30 was $373.00K, a 4044.44% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. research and development expense for the quarter ending 2026-03-31 was $275.00K, a 1275.00% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. research and development expense for the quarter ending 2025-12-31 was $98.00K, a 70.39% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. research and development expense for the quarter ending 2025-09-30 was $52.00K, a 173.68% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. research and development expense for fiscal 2025 was $179.00K, a 51.49% decline from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. research and development expense for fiscal 2024 was $369.00K, a 80.96% decline from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. research and development expense for fiscal 2023 was $1.94M, a 151.42% increase from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. research and development expense for fiscal 2022 was $770.83K, a 43.09% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $373.00K 10-Q · filed 2026-08-13 | $648.00K 10-Q · filed 2026-08-13 | $746.00K derived: sum of 3 quarters · filed 2026-08-13 | $798.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $275.00K 10-Q · filed 2026-05-14 | $373.00K derived: sum of 2 quarters · filed 2026-05-14 | $425.00K derived: sum of 3 quarters · filed 2026-05-14 | $434.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2025-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $150.00K derived: sum of 2 quarters · filed 2026-03-31 | $159.00K derived: sum of 3 quarters · filed 2026-03-31 | $179.00K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $52.00K 10-Q · filed 2025-11-13 | $61.00K derived: sum of 2 quarters · filed 2025-11-13 | $81.00K 10-Q · filed 2025-11-13 | $412.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2025-06-30 | $9.00K 10-Q · filed 2025-08-14 | $29.00K 10-Q · filed 2025-08-14 | $360.00K derived: sum of 3 quarters · filed 2025-08-14 | $379.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2025-03-31 | $20.00K 10-Q · filed 2025-05-15 | $351.00K derived: sum of 2 quarters · filed 2025-05-15 | $370.00K derived: sum of 3 quarters · filed 2025-11-13 | $376.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-12-31 | $331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $350.00K derived: sum of 2 quarters · filed 2025-11-13 | $356.00K derived: sum of 3 quarters · filed 2025-11-13 | $369.00K 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | $19.00K 10-Q · filed 2025-11-13 | $122.41K 10-Q · filed 2024-11-14 | $25.00K derived: sum of 2 quarters · filed 2025-11-13 | $38.00K 10-Q · filed 2025-11-13 | $249.97K 10-Q · filed 2024-11-14 | $250.03K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $6.00K 10-Q · filed 2025-08-14 | $11.69K 10-Q · filed 2024-08-14 | $19.00K 10-Q · filed 2025-08-14 | $127.56K 10-Q · filed 2024-08-14 | $231.03K derived: sum of 3 quarters · filed 2025-08-14 | $1.92M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $116.00K 10-Q · filed 2025-05-15 | $115.87K 10-Q · filed 2024-05-15 | $225.03K derived: sum of 2 quarters · filed 2025-05-15 | $1.92M derived: sum of 3 quarters · filed 2025-05-15 | $1.94M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $109.03K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.80M derived: sum of 2 quarters · filed 2025-03-31 | $1.82M derived: sum of 3 quarters · filed 2025-03-31 | $1.94M 10-K · filed 2025-03-31 | $1.94M 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $1.69M 10-Q · filed 2024-11-14 | $1.71M derived: sum of 2 quarters · filed 2024-11-14 | $1.83M 10-Q · filed 2024-11-14 | $2.08M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $16.86K 10-Q · filed 2024-08-14 | $135.76K 10-Q · filed 2024-08-14 | $385.35K derived: sum of 3 quarters · filed 2024-08-14 | $583.85K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $118.91K 10-Q · filed 2024-05-15 | $368.50K derived: sum of 2 quarters · filed 2024-05-15 | $567.00K derived: sum of 3 quarters · filed 2024-05-15 | $680.37K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $249.59K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $448.09K derived: sum of 2 quarters · filed 2024-04-01 | $561.46K derived: sum of 3 quarters · filed 2024-04-01 | $770.83K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $198.50K 10-Q · filed 2023-11-14 | $311.88K derived: sum of 2 quarters · filed 2023-11-14 | $521.24K 10-Q · filed 2023-11-14 | $696.92K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $113.38K 10-Q · filed 2023-08-14 | $322.74K 10-Q · filed 2023-08-14 | $498.42K derived: sum of 3 quarters · filed 2023-08-14 | $564.89K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $209.36K 10-Q · filed 2023-05-15 | $385.04K derived: sum of 2 quarters · filed 2023-05-15 | $451.51K derived: sum of 3 quarters · filed 2023-05-15 | $678.25K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $175.68K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $242.15K derived: sum of 2 quarters · filed 2023-03-27 | $468.89K derived: sum of 3 quarters · filed 2023-03-27 | $538.68K 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | $66.47K 10-Q · filed 2022-11-14 | $293.21K derived: sum of 2 quarters · filed 2022-11-14 | $363.00K 10-Q · filed 2022-11-14 | $439.19K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $226.74K 10-Q · filed 2022-08-15 | $296.53K 10-Q · filed 2022-08-15 | $372.73K derived: sum of 3 quarters · filed 2022-08-15 | $460.19K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $69.79K 10-Q · filed 2022-05-16 | $145.98K derived: sum of 2 quarters · filed 2022-05-16 | $233.45K derived: sum of 3 quarters · filed 2022-05-16 | $329.15K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $76.19K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $163.66K derived: sum of 2 quarters · filed 2022-03-31 | $259.36K derived: sum of 3 quarters · filed 2022-03-31 | $417.00K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $87.47K 10-Q · filed 2021-11-15 | $183.17K derived: sum of 2 quarters · filed 2021-11-15 | $340.81K 10-Q · filed 2021-11-15 | $585.02K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $95.71K 10-Q · filed 2021-08-16 | $253.34K 10-Q · filed 2021-08-16 | $497.56K derived: sum of 3 quarters · filed 2021-08-16 | $649.96K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $157.64K 10-Q · filed 2021-05-18 | $401.85K derived: sum of 2 quarters · filed 2021-05-18 | $554.26K derived: sum of 3 quarters · filed 2021-05-18 | $641.43K derived: sum of 4 quarters · filed 2021-05-18 | ||||
| 2019-12-31 | $244.22K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $396.62K derived: sum of 2 quarters · filed 2021-03-29 | $483.80K derived: sum of 3 quarters · filed 2021-03-29 | $615.62K 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $152.40K 10-Q · filed 2020-11-12 | $239.58K derived: sum of 2 quarters · filed 2020-11-12 | $371.41K 10-Q · filed 2020-11-12 | |||||
| 2019-06-30 | $87.18K 10-Q · filed 2020-08-11 | $219.00K 10-Q · filed 2020-08-11 | ||||||
| 2019-03-31 | $131.83K 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | $357.08K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |